(Sharecast News) - Europe's drug regulator has backed Moderna's novel vaccine for respiratory syncytial virus, the US pharmaceutical firm announced on Friday.
Moderna said the European Medicines Agency's Committee for Medicinal Products for Human Use had adopted a "positive opinion" recommending the granting of marketing authorisation in the European Union for...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE